Completed PHASE3 INTERVENTIONAL 2-arm NCT03248661

Assessing Repeat Fit Testing for CRC (ARFT)

Assessing Repeat Annual FIT Screening for Colo-Rectal Cancer (CRC)

Sponsor: Centers for Disease Control and Prevention

Updated 6 times since 2017 Last updated: Feb 19, 2019 Started: Aug 1, 2015 Primary completion: Sep 25, 2018 Completion: Sep 25, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Colo-rectal Cancer and is currently completed. Centers for Disease Control and Prevention leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Mar 2019 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention
Richard Crosby

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States